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SUMMARY
Tumormetastasis is the primary cause of death of cancer patients. Understanding themolecularmechanisms
underlying tumor metastasis will provide potential drug targets. We report here that Orai1 and STIM1, both of
which are involved in store-operated calcium entry, are essential for breast tumor cell migration in vitro and
tumormetastasis inmice. Reduction of Orai1 or STIM1 byRNA interference in highlymetastatic human breast
cancer cells or treatment with a pharmacological inhibitor of store-operated calcium channels decreased
tumor metastasis in animal models. Our data demonstrate a role for Orai1 and STIM1 in tumor metastasis
and suggest store-operated calcium entry channels as potential cancer therapeutic targets.INTRODUCTION
Despite the significant improvement in both diagnostic and
therapeutic modalities for the treatment of cancer patients,
metastasis still represents the major cause of mortality, being
responsible for90%of all cancer deaths (Christofori, 2006; Ha-
nahan and Weinberg, 2000). Metastasis is the multistep process
wherein a primary tumor spreads from its initial site to secondary
tissues/organs (Fidler, 2003; Weiss, 2000). To disseminate from
primary tumors and establish secondary tumors, cancer cells
must succeed in migration/invasion, infiltration into circulation,
survival in the circulation, penetrating through capillary endo-
thelia, and proliferating to form secondary tumors in distant
organs. Failure at any of these steps can block the entire meta-
static process. Since tumor spreading is responsible for the
majority of deaths of cancer patients, development of thera-
peutic agents that inhibit tumor metastasis is highly desirable.
Such agents could be effective in restraining new tumor forma-
tion when earlier therapy or surgery has failed, or in increasing
successful containment of solid tumors in combination therapy
with other agents. To achieve the goal of preventing tumor
metastasis, a better understanding of themolecular components
involved in tumor metastasis is needed.
One of the critical steps during tumor metastasis is tumor cell
migration and invasion, which are responsible for the entry of
tumor cells into lymphatic and blood vessels as well as the
extravasation of tumor cells into the secondary organs (Mareel
and Leroy, 2003; Steeg, 2006). Cell migration is a sequential
and interrelated multistep process involving the formation of
lamellipodia/membrane protrusions at the front edge, cycles of
adhesion and detachment, cell body contraction, and tail retrac-
tion (Ridley et al., 2003). Focal adhesion turnover plays a pivotal
role in cell migration. Small, nascent focal adhesions at the
leading edge serve as traction points for the forces that move
the cell body forward. On the other hand, disassembly of focal
adhesions at the rear allows the retraction of the rear and net
translocation of the cell in the direction of movement (Webb
et al., 2002). To extravasate through capillary endothelium,
cancer cells need to adhere to endothelial cells. Duringmigration
and invasion, the adhesions between cancer cells and the extra-
cellular matrix also undergo disassembly (Webb et al., 2002).
Recently, 20% of the cancer candidate genes in breast and
colorectal cancers were found to be adhesion-related genes,
implying the significance of cell adhesion in cancer progression
(Sjoblom et al., 2006).
The ubiquitous second messenger Ca2+ is one of the critical
regulators of cell migration (Pettit and Fay, 1998). We and others
have previously shown that Ca2+ influx is essential for the migra-
tionof variouscell types, including tumorcells (KomuroandRakic,
1993; Leeet al., 1999;Marks andMaxfield, 1990;Nishiyamaet al.,
SIGNIFICANCE
The primary cause of death of cancer patients is tumor metastasis, that is, the spreading of tumors from the primary site to
secondary sites. Thus, development of drugs targeting this spreading process is desirable. Cell migration is one of the key
steps in tumor spreading. Therefore, it is likely that inhibitors of cell migration can block tumor metastasis. The proteins
Orai1 and STIM1 have recently been identified to be involved in calcium influx from the extracellular environment to the
inside of cells. We show here that Orai1 and STIM1 are required for tumor cell migration, invasion, and metastasis. Hence,
Orai1 and STIM1 are potential targets for therapeutic intervention to inhibit tumor metastasis.
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Orai1 and STIM1 in Tumor MetastasisFigure 1. Ca2+ Influx Is Required for Serum-Induced Cell Migration
(A) Wound-healing assays showing that SKF96365 (20 mM) inhibits the migration of MEFs. Nimodipine (20 mM), DL-2-amino-5-phosphonopentanoic acid (2-AP)
(1 mM), and CNQX (10 mM) had no effect on MEF migration. Scale bar = 100 mm.
(B) Boyden chamber assay showing that SKF96365 (10 mM) decreases serum-induced migration of MDA-MB-231 human breast tumor cells.
(C) Boyden chamber assay showing that SKF96365 (10 mM) decreases the migration of 4T1 mouse mammary tumor cells induced by serum.
(D) Fluo-3 Ca2+ imaging indicates that SKF96365 (10 mM) and EGTA (2 mM) treatments decrease serum-induced Ca2+ influx in MEFs.
Data are either representative of three similar experiments or are shown as mean ± SD of five experiments.2003; Yang and Huang, 2005). In nonexcitable cells, store-oper-
ated calcium influx is the predominant Ca2+ entry mechanism
(Lewis, 2007; Parekh and Penner, 1997). Recent studies have
identified two genes, STIM1 (stromal interaction molecule 1) and
Orai1 (also namedCRACM1), that are responsible for store-oper-
ated Ca2+ entry (Feske et al., 2006; Liou et al., 2005; Roos et al.,
2005; Vig et al., 2006; Zhang et al., 2006). While STIM1 serves
as a Ca2+ sensor, Orai1 is an essential pore-forming component
of the store-operated Ca2+ entry channel (Prakriya et al., 2006;
Yeromin et al., 2006). Coexpression of Orai1 and STIM1 is suffi-
cient to reconstitute the store-operated calcium channel function
(Mercer et al., 2006; Peinelt et al., 2006; Soboloff et al., 2006).
Store-operated calcium influx controls a variety of physiological
and pathological processes (Dolmetsch et al., 1998; Fanger
et al., 1995; Feske et al., 2005; Lewis, 2001; Mogami et al.,
1997; Yoo et al., 2000). However, the roles of store-operated
calcium influx in tumor metastasis have not been investigated.
Here we examined the role of Orai1 and STIM1 in breast tumor
cell migration, invasion, and metastasis.
RESULTS AND DISCUSSION
Store-Operated Ca2+ Channels Are Critical
for Serum-Induced Cell Migration
We have previously shown that Ca2+ influx is required for both
growth factor- and serum-induced fibroblast cell migration (Yang
and Huang, 2005). To understand the molecular mechanisms, we
investigated the effect on cell migration of pharmacological inhibi-
tors for various ion channels that mediate Ca2+ influx (Figure 1A).
While inhibitors of voltage-gated Ca2+ channels (nimodipine),
NMDA receptors (2-AP), or AMPA receptors (CNQX) had no effect
on serum-induced fibroblast cell migration, an inhibitor of store-
operated Ca2+ entry (SKF96365) blocked serum-induced cell
migration (Figure 1A). In these wound-healing assays, fibroblasts
were grown to confluency, and a ‘‘wound’’ wasmade in themiddle
of the tissue culture plate with a pipette tip. In the presence of
serum, cells would migrate and fill the gap after 12 hr (Guo
et al., 2007; Shan et al., 2006; Wang et al., 2006; Yang and Huang,
2005) (Figure 1A). The inhibitory effect of SKF96365 on cell migra-
tion was confirmed with different types of cells and by a different
method of measuring cell migration. Using a Boyden chamber
assay (counting cells migrating through a porous membrane), we
observed that SKF96365 inhibited the migration of MDA-MB-231
human breast cancer cells and 4T1 mouse mammary tumor cells
(Figures 1B and 1C). To confirm that SKF96365 blocked serum-
induced Ca2+ influx, Fluo-3 (a fluorescent Ca2+ indicator)-based
Ca2+ measurement was performed. Normally, a serum-induced
Ca2+ response consists of two phases, a peak phase contributed
by Ca2+ release from intracellular Ca2+ stores and a plateau phase
contributed by Ca2+ influx (Berridge et al., 2003). As shown in
Figure 1D, SKF96365 decreased the amplitude of the plateau
phase of the serum-induced Ca2+ response without affecting the
peak phase. Similar results were observed with EGTA, which
chelates extracellular Ca2+ (Figure 1D). These pharmacological
inhibitordatashowthatblockingCa2+ influx inhibitsserum-induced
migration of different types of cells, including breast tumor cells.
We next employed a different approach to verify the role of
store-operated Ca2+ entry in cell migration. Recent studies
have identified STIM1 and Orai1, which are responsible for
store-operated Ca2+ entry (Feske et al., 2006; Liou et al., 2005;
Roos et al., 2005; Vig et al., 2006; Zhang et al., 2006). To examine
whether STIM1 and Orai1 are important molecular componentsCancer Cell 15, 124–134, February 3, 2009 ª2009 Elsevier Inc. 125
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Orai1 and STIM1 in Tumor Metastasisinvolved in cell migration, we used RNA interference (RNAi) to
knock down STIM1 and Orai1 in MDA-MB-231 human breast
cancer cells. The successful knockdown of STIM1 or Orai1
mRNA was confirmed by western blots with anti-STIM1 or
anti-Orai1 antibodies (Figure 2A). Furthermore, the reduction of
functional store-operated Ca2+ entry was verified by Fluo-
3-based measurements (Figure 2B). Store-operated Ca2+ chan-
nels are activated when internal Ca2+ stores are empty (Lewis,
Figure 2. STIM1 and Orai1 Are Required for Serum-Induced Cell Migration
(A) Western blots showing that STIM1 siRNA and Orai1 siRNA decrease the protein levels of STIM1 and Orai1, respectively, in MDA-MB-231 cells. One hundred
micrograms of total cellular protein was loaded onto each lane.
(B) Fluo-3 Ca2+ measurement indicates that STIM1 siRNA and Orai1 siRNA decrease store-operated Ca2+ influx in MDA-MB-231 cells. TG, thapsigargin.
(C) Fluo-3 Ca2+ measurement indicates that siRNA-resistant STIM1 or Orai1 constructs restore Ca2+ influx in STIM1 or Orai1 siRNA-treated cells, respectively.
(D) STIM1 siRNA and Orai1 siRNA decrease serum-induced migration of MDA-MB-231 cells.
(E) STIM1 siRNA and Orai1 siRNA decrease serum-induced migration of MDA-MB-231 cells in Boyden chamber assays with different coatings (including fibro-
nectin, gelatin, and poly-D-lysine) as well as uncoated chamber filter membranes.
(F) Migrating traces, obtained by tracking the movement of cells over the course of 2 hr, of MDA-MB-231 cells expressing control siRNA or STIM1 and Orai1
siRNAs.
(G) Scattered dot plot of cell migration speed obtained by cell tracking. Nineteen control siRNA-treated cells and fourteen STIM1 and Orai1 siRNA-treated cells
were tracked. Horizontal bars represent mean ± SEM (p < 2 3 105) as calculated by one-tailed Student’s t test.
(H) Overexpression of STIM1 and Orai1 in MCF-10A epithelial cells enhances the migration of MCF-10A cells.
Data are either representative of three similar experiments or are shown as mean ± SD of five experiments. *p < 0.05.
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Orai1 and STIM1 in Tumor Metastasis2007). Thapsigargin was used to empty the intracellular Ca2+
stores in the absence of extracellular Ca2+. Ca2+ influx was then
measured by addition of 2 mM extracellular Ca2+. Both STIM1
and Orai1 siRNAs reduced the level of Ca2+ influx compared to
control siRNA against LacZ (Figure 2B). Re-expression of
siRNA-resistant STIM1 or Orai1 constructs (generated by
mutating the DNA sequences targeted by siRNAs without
changing the amino acid sequences) restored the Ca2+ influx
(Figure 2C). Moreover, as measured by Boyden chamber assay,
serum-induced MDA-MB-231 cell migration was significantly
reducedbySTIM1orOrai1 siRNA treatments (Figure 2D). Several
different coatings (including fibronectin, gelatin, and poly-D-
lysine) as well as no-coating of the chamber filter membrane
produced similar results; STIM1 and Orai1 siRNAs decreased
the migration of MDA-MB-231 cells by 60%–85% (Figure 2E). A
second set of siRNAs for STIM1 and Orai1 produced similar
results (data not shown). Re-expression of siRNA-resistant
STIM1orOrai1constructs rescued theserum-inducedcellmigra-
tion (Figure 2D). Live-cell tracking revealed that STIM1 siRNA and
Orai1 siRNA treatment decreased the migration speed of MDA-
MB-231 cells by 50% (Figures 2F and 2G). In addition, overex-
pression of STIM1 and Orai1 in MCF-10A epithelial cells (with
lower levels of endogenous STIM1 and Orai1 than in MDA-MB-
231 cells) enhanced the migration of MCF-10A cells (Figure 2H).
STIM1 andOrai1 siRNA treatments did not affect the proliferation
of MDA-MB-231 cells (data not shown). Hence, both pharmaco-
logical and RNAi data demonstrate that store-operated Ca2+
channels are critical for serum-induced cell migration.
Store-Operated Ca2+ Channels Modulate Focal
Adhesion Turnover
To further investigate the mechanism by which Ca2+ influx
controls cell migration, we studied the effect of blocking Ca2+
influx on several steps of cell migration. We found that blocking
Ca2+ influx impaired the turnover of focal adhesions (Figure 3)
but had no effect on lamellipodium formation (data not shown).
Focal adhesions are the cell adhesions mediated by interaction
of integrin with the extracellular matrix (Guo and Giancotti,
2004; Webb et al., 2002). Assembly and disassembly of focal
adhesions are required for cell migration (Webb et al., 2002).
Newly assembled focal adhesions at the protrusion front of
migrating cells provide anchorage points for the actin meshwork
to generate traction forces that move the cell body forward, while
disassembly of focal adhesions in the back is necessary for the
retraction of the trailing tail. Focal adhesions can be visualized
by immunostaining for vinculin, amajor component of focal adhe-
sions. Murine embryonic fibroblasts (MEFs) plated on gelatin-
coated glass coverslips were treated with serum with or without
pharmacological inhibitors for 2 hr, fixed with 3.7% formalde-
hyde, and then stainedwith vinculin antibody. In control cells, vin-
culin stainingshowedapunctatepatternof small focal adhesions,
typical of fibroblasts (Figure 3A). Chelation of extracellular Ca2+
with EGTA induced large peripheral adhesions while decreasing
the number of adhesions in the middle of the cell (Figures 3A
and 3B). Similarly, treatment of fibroblasts with SKF96365
increased the size of focal adhesions around the periphery of
the cells (Figures 3A and 3B). Large peripheral focal adhesions
were observed in 74% ± 5.7% of cells treated with EGTA (n =
110), 77% ± 8.4% of cells treated with Ni2+ (another Ca2+ influx
blocker) (n = 179), and 86% ± 3.5% of cells treated with
SKF96365 (n = 150), but in only 10% of control cells (n = 231)
(Figure 3B). On the other hand, treatment of fibroblastswith inhib-
itors of L-type Ca2+ channels (nimodipine), NMDA receptors
(2-AP), or AMPA receptors (CNQX) did not affect the size of focal
adhesions (Figure 3A). Next, to confirm these observations with
a different cell type and a different approach, we investigated
focal adhesions in MDA-MB-231 human breast tumor cells
treated with STIM1 and Orai1 siRNAs (Figure 3C). While focal
adhesions were small in control siRNA-treated MDA-MB-231
cells, STIM1 and Orai1 siRNA-treated cells displayed larger
peripheral focal adhesions (Figure 3C, upper panels with higher
magnification). Re-expression of siRNA-resistant STIM1 or Orai1
constructs reduced the size of focal adhesions to those observed
in control siRNA-treated cells (Figure 3C). Quantitative analyses
of focal adhesions showed that both the relative integrated inten-
sity and the area of focal adhesions were increased by treatment
with STIM1 or Orai1 siRNAs (Figures 3D and 3E). Compared to
control siRNA-treated cells, the size of focal adhesions in
STIM1 or Orai1 siRNA-treated cells was 3-fold larger and the
intensity was 7-fold greater. These increases were prevented
by the reintroduction of siRNA-resistant STIM1 or Orai1
constructs (Figures 3Dand3E). Since largeperipheral focal adhe-
sions are often correlated with turnover defects, these data indi-
cate that store-operated Ca2+ channels may regulate cell migra-
tion at least partly through modulating focal adhesion turnover.
Since focal adhesion turnover includes focal adhesion
assembly (formation of focal complexes) and focal adhesion
disassembly, we used live-cell imaging to quantify the rates of
focal adhesion assembly and disassembly (Figures 4A–4D; see
also Movies S1 and S2 available online). To monitor the dynamic
turnover of focal adhesions, we transfected paxillin-GFP into
fibroblasts. Paxillin is another major component of focal adhe-
sions. From the live-cell time-lapse recordings, we observed
that SKF96365 treatment prevented formation of new focal
complexes at cell protrusions and also slowed the disassembly
of focal adhesions. In control cells, focal adhesions assembled
at a rate of 0.22/min and disassembled at a rate of 0.21/min,
consistent with previous reports (Webb et al., 2004) (Figures
4A, 4C, and 4D). In contrast, formation of new focal complexes
and disassembly of focal adhesions in SKF96365-treated cells
were delayed, with an assembly rate of 0.046/min and a disas-
sembly rate of 0.021/min (Figures 4B–4D). Moreover, nascent
focal adhesions generally accompanied the formation of new
membrane protrusions in control cells, while nascent adhesions
were usually absent from new protrusions in SKF96365-treated
cells. Consequently, when migrating cells were treated with
SKF96365, new protrusions failed to attach to the substratum
and thus quickly withdrew (Movies S1 and S2). Hence, blocking
Ca2+ influx affects both the assembly and disassembly of focal
adhesions, which may impair traction force generation in
migrating cells.
The Small GTPases Ras and Rac Can Rescue
the Defects of Focal Adhesion Turnover
and Cell Migration Induced by Blocking Ca2+ Influx
To further understand the mechanism by which Ca2+ influx regu-
lates focal adhesion turnover, we investigated the participation
of small GTPases, since Ras and Rac are regulators of focal
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Orai1 and STIM1 in Tumor MetastasisFigure 3. Blocking Ca2+ Influx Impairs Focal Adhesion Turnover
(A) Vinculin staining of fibroblasts. Treatment with EGTA (2mM) or SKF96365 (20 mM) induced large peripheral focal adhesions inMEFs. Nimodipine (20 mM), 2-AP
(1 mM), or CNQX (10 mM) had no effect. SOC: store-operated Ca2+ entry channel. Scale bar = 10 mm.
(B) Quantification of cells with large peripheral focal adhesions. 1mMNi2+, 2mMEGTA, or 20 mMSKF96365 was used for blocking Ca2+ influx. Data are shown as
mean ± SD of three experiments.
(C) Vinculin staining of MDA-MB-231 cells. STIM1 siRNA andOrai1 siRNA induced large peripheral focal adhesions inMDA-MB-231 cells. Amagnified view of the
respective boxed area is shown above each main image. Scale bar = 20 mm for main images and 4 mm for magnified images.
(D and E) Quantification of focal adhesions. The relative integrated intensity (D) and the area (E) of focal adhesions under different conditions were quantified. Data
are expressed as mean ± SEM of 600–1000 focal adhesions in 10–15 cells and were quantified for each type of cell. *p < 105.adhesion turnover (Ridley andHall, 1992; Schlaepfer andHunter,
1998). We treated cells with the Ca2+ influx inhibitor SKF96365,
and this treatment induced large focal adhesions due to the
defective focal adhesion turnover (red vinculin staining in Fig-
ure 4E). Expression of constitutively active Ras(G12V) rescued
this defect and led to smaller focal complexes (green-labeled
cells in Figure 4E). Similarly, constitutively active Rac1(G12V)
rescued the SKF96365 effect on focal adhesion turnover (Fig-
ure 4F). Furthermore, dominant-negative Ras and Rac1 mutants
induced the formation of larger focal adhesions in MDA-MB-231
cells, implying that these small GTPases are required for focal
adhesion turnover (data not shown). Moreover, these rescue
effects could be extended to cell migration. While Orai1 and
STIM1 siRNA treatment decreased the migration of MDA-MB-
231 cells, expression of constitutively active Ras(G12V) rescued
the migration of these siRNA-treated cells (Figure 4G).
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Orai1 and STIM1 in Tumor MetastasisFigure 4. Blocking Ca2+ Influx Impairs the Assembly and Disassembly of Focal Adhesions
(A and B) Live-cell imaging of paxillin-GFP-transfected MEFs in the absence (A) or presence (B) of SKF96365. Scale bar = 10 mm.
(C and D) Quantification of assembly (C) and disassembly (D) of focal adhesions from live-cell time-lapse recordings of paxillin-GFP-transfected cells.
(E and F) MEFs were infected with the retroviruses pBMN-H-Ras(G12V)-IRES-GFP (E) or pBMN-Rac1(G12V)-IRES-GFP (F). These cells were then treated with
10 mM SKF96365 for 2 hr and stained with anti-vinculin antibody. Red indicates vinculin staining; green indicates GFP. Scale bar = 10 mm.
(G and H) MDA-MB-231 cells were infected with the retroviruses pBMN-H-Ras(G12V)-IRES-GFP (G) or pBMN-Rac1(G12V)-IRES-GFP (H). Some of these cells
were then treated with Orai1 and/or STIM1 siRNAs. Cells were then used for Boyden chamber assay.
(I) Activation of Rac by Ca2+ influx. Active Rac (Rac-GTP) proteins were precipitated with the Rac-binding domain of PAK (GST-PBD). Western blots were per-
formed with anti-Rac antibody. Lane 1, starved MDA-MB-231 cells; lane 2, starved MDA-MB-231 cells treated with 500 nM ionomycin for 30 min.
Data are representative of three similar experiments or are shown as mean ± SD of three experiments. *p < 0.05.Constitutively active Rac1(G12V) also rescued the migration
defect induced by Orai1 siRNA or STIM1 siRNA treatments
(Figure 4H). In addition, Ca2+ influx (induced by ionomycin treat-
ment) activated Rac by2-fold in MDA-MB-231 cells (Figure 4I).
These data suggest that the small GTPases Ras and Rac can
rescue the defects of focal adhesion turnover and cell migration
induced by blocking Ca2+ influx.
Orai1 and STIM1 siRNAs Inhibit Human Breast Tumor
Metastasis in a Mouse Model
During the multistep process of tumor metastasis, tumor cell
migration and invasion are critical (Mareel and Leroy, 2003;
Steeg, 2006). We first investigated the role of STIM1 and Orai1
in tumor cell invasion. Control siRNA-, STIM1 siRNA-, or Orai1
siRNA-treated MDA-MB-231 human breast tumor cells were
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Orai1 and STIM1 in Tumor MetastasisFigure 5. STIM1 and Orai1 Are Critical for Tumor Cell Invasion and Metastasis
(A) STIM1 siRNA and Orai1 siRNA treatments decrease the invasion of MDA-MB-231 cells. *p < 0.05.
(B) EGTA (2 mM), Ni2+ (1 mM), and SKF96365 (20 mM) decrease the invasion of MDA-MB-231 cells.
(C) Overexpression of STIM1 and Orai1 in MCF-10A epithelial cells enhances invasion.
(D) Representative bioluminescent imaging of mice injected with MDA-MB-231 cells stably expressing control siRNA (n = 7), STIM1 siRNA (n = 9), or Orai1 siRNA
(n = 8). The photon flux scale is shown at the right.
(E) Quantification of bioluminescent imaging data.
Data in (A)–(C) are shown as mean ± SD of three experiments; data in (D) are representative of seven, nine, or eight similar experiments; and data in (E) are shown
as mean ± SD of seven, eight, or nine experiments.allowed to migrate through Matrigel. As shown in Figure 5A,
fewer STIM1 or Orai1 siRNA-treated MDA-MB-231 cells than
control siRNA-treated tumor cells invaded the Matrigel. Re-
expression of siRNA-resistant STIM1 or Orai1 constructs
rescued the invasion of the STIM1 or Orai1 siRNA-treated cells
(Figure 5A). Furthermore, blocking Ca2+ influx with EGTA, Ni2+,
or SKF96365 similarly decreased the number of MDA-MB-231
tumor cells invading the Matrigel (Figure 5B). Moreover, expres-
sion of STIM1 and Orai1 in MCF-10A epithelial cells enhanced
the invasion of these cells (Figure 5C). These results suggest
that STIM1 and Orai1 are needed for tumor cell invasion.
To extend these studies to an animal model, we studied the
metastasis of MDA-MB-231 human breast tumor cells in immu-
nodeficient NOD/SCID mice using a recently developed triple-
modality reporter that encodes a fusion protein consisting of
thymidine kinase, GFP, and luciferase (Minn et al., 2005a; Pono-
marev et al., 2004). In these xenograft experiments, MDA-MB-
231 tumor cells expressing the GFP and luciferase reporter
gene were injected into immunodeficient mice through the tail
vein (Minn et al., 2005a; Ponomarev et al., 2004). Luciferase-
based noninvasive bioluminescence imaging was used to
monitor the presence of tumor cells. Most of these tumor cells
became trapped in the capillaries of the lungs shortly after injec-
tion (due to size restrictions imposed by mouse capillaries,
human tumor cells are rarely able to pass from the arterial to
the venous system or vice versa by way of the lung; Minn et al.
[2005b]) (Figure 5D, day 0). A substantial attenuation of biolumi-
nescence signal was observed within the first day, indicating that
cells that failed to metastasize were not able to survive (Figures
5D and 5E). Progressively increasing signals after day 8 in mice
with control siRNA-treated tumor cells stably expressing siRNA
indicated that cells had succeeded in metastasizing and
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Orai1 and STIM1 in Tumor MetastasisFigure 6. Blocking Ca2+ Influx Inhibits Tumor Metastasis
Histological analyses showing staining of lung tissue sections from untreated mice, mice injected with MDA-MB-231 cells stably expressing control siRNA, mice
injected with MDA-MB-231 cells stably expressing STIM1 siRNA, and mice injected with MDA-MB-231 cells stably expressing Orai1 siRNA. The top panels are
stained with hematoxylin and eosin (H&E). T indicates tumor metastases. The bottom panels show GFP fluorescence (green), DAPI for nuclei (blue), and rhoda-
mine-conjugated phalloidin for actin polymers (red). Data are representative of three similar experiments. Scale bar = 100 mm.proliferating (Figures 5D and 5E). Strikingly, the presence of
STIM1 or Orai1 siRNA-treated cells stably expressing siRNAs
in the lung was much less than control siRNA-treated cells at
day 1 and practically undetectable after day 8 (Figures 5D and
5E). Therefore, STIM1 and Orai1 siRNAs significantly inhibit
breast tumor metastasis.
To further confirm the defective tumor metastasis, we per-
formed histological analyses of lung tissues from xenografted
mice (Figure 6). Tissues were isolated and sectioned, and hema-
toxylin and eosin (H&E) staining showed normal structure of
lungs from noninjected mice (without tumors) and from mice in-
jected with STIM1 or Orai1 siRNA-treated MDA-MB-231 tumor
cells (Figure 6). In contrast, lung tissues from mice injected
with control siRNA-treated tumor cells were heavily infiltrated
by metastasized human breast tumor cells (Figure 6). The iden-
tity of tumor cells in the lung tissue was confirmed by GFP fluo-
rescence since the injected MDA-MB-231 tumor cells were
labeled with GFP (Figure 6). These results demonstrate that
STIM1 and Orai1 are critical for breast tumor metastasis in
a mouse model.
The Store-Operated Channel Blocker SKF96365 Inhibits
Breast Tumor Metastasis in Mouse Models
We further investigated whether the pharmacological inhibitor
SKF96365 could be used as a tumor metastasis inhibitor in
amousemodel.We first examined lungmetastasis of 4T1mouse
mammary tumor cells in mice with or without treatment with
SKF96365. The 4T1 mouse tumor closely mimics human breast
cancer in its anatomical site, immunogenicity, growth character-
istics, and metastatic properties (Pulaski and Ostrand-Rosen-
berg, 1998; Shan et al., 2005). From the mammary gland, the
4T1 tumor spontaneously metastasizes to a variety of target
organs including lung, bone, brain, and liver. Seven days after
implantation of 4T1 tumor cells in the mammary glands of
BALB/c mice, we injected the mice with control PBS or
SKF96365 (daily at 10mg/kg). After 20 days, themicewere sacri-
ficed and examined for metastasis in the lungs (Shan et al.,
2005). Whereas mice injected with control PBS exhibited large
numbers of metastasized 4T1 cells in the lungs, the number of
metastasized 4T1 cells in the lungs of mice treated with
SKF96365 was reduced by 80% (Figure 7A). These results
demonstrate that SKF96365 is a potent inhibitor of 4T1 tumor
cell metastasis from the mammary gland to the lungs.
The antimetastatic effect of the store-operated channel blocker
SKF96365 was next examined in a xenograft mouse model with
MDA-MB-231 human breast tumor cells. After tail-vein injection
of tumor cells, NOD/SCID mice were intraperitoneally adminis-
tered 10 mg/kg SKF96365 daily for 4 weeks. The metastasis of
tumor cells to the lungs was significantly inhibited after one
week of SKF96365 treatment (Figures 7B and 7C). More impor-
tantly, even at day 42, two weeks after withdrawal of SKF96365,
no increase in metastasis was observed (Figure 7B). Therefore,
SKF96365 is an effective inhibitor of breast tumor metastasis in
mouse models.
Conclusion
We have shown that STIM1 and Orai1 are essential for tumor cell
migration in vitro and tumor metastasis in mice. The molecular
mechanism by which Ca2+ influx regulates cell migration at least
partly involves the modulation of focal adhesion turnover. Our
data demonstrate a role for store-operated Ca2+ entry in tumor
metastasis, making STIM1 and Orai1 attractive targets for ther-
apeutic intervention.
The molecular mechanism by which Ca2+ regulates focal
adhesion turnover is incompletely understood. Focal adhesions
are dynamic structures under tight spatial control at the subcel-
lular level to enable localized responses to extracellular cues.
Both protein tyrosine phosphorylation and proteolysis of
proteins in focal adhesions are involved in focal adhesion turn-
over (Webb et al., 2002). Increase of cellular Ca2+ could increase
the activity of the tyrosine kinase FAK (focal adhesion kinase)
and the calcium-dependent protease calpain in focal adhesions
(Achison et al., 2001; Dourdin et al., 2001; Huttenlocher et al.,
1997; Siciliano et al., 1996). FAK is a critical regulator of focal
adhesion turnover. In FAK-deficient fibroblasts, decreased
migration is accompanied by an increased number of focal
adhesions (Ilic et al., 1995; Ren et al., 2000). One of the biochem-
ical functions of FAK is to activate Rac through p130Cas, Crk,
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pain could cleave talin at adhesion sites, leading to more rapid
disassembly rates through additional downstream control of
paxillin, vinculin, and zyxin (Franco et al., 2004). Furthermore,
other Ca2+-sensitive proteins such as myosin light-chain kinase
and calcineurin could alsomediate theCa2+ effect on focal adhe-
sion turnover (Eddy et al., 2000; Lawson and Maxfield, 1995).
Moreover, in addition to focal adhesions, podosomes and
invadopodia are also adhesion structures, and invadopodia
contribute to cancer invasion (Linder, 2007).
Focal adhesion turnover is critical for tumormetastasis. Block-
ing store-operated Ca2+ influx slows down focal adhesion turn-
over, resulting in larger focal adhesions and consequently
stronger adherence. Such strong adherence could impede the
fast migration of cells, including metastatic cancer cells. There-
fore, agents that block store-operated Ca2+ channels, such as
SKF96365, siRNAs for Orai1 and STIM1, or antibodies that
specifically block the channel activity of store-operated calcium,
are potential therapeutics for tumor metastasis.
EXPERIMENTAL PROCEDURES
Cell Lines
MDA-MB-231 cells; GPG29 retrovirus packaging cells; and the TGL reporter
construct encoding herpes simplex virus thymidine kinase 1, green fluorescent
protein (GFP), and firefly luciferase were gifts from the laboratories of J.
Massague´ and V. Ponomarev at Memorial Sloan-Kettering Cancer Center.
MEFs were derived from day 14 mouse embryos. Cells were grown in high-
glucose DMEM with 10% fetal bovine serum. For bioluminescence labeling,
MDA-MB-231 cells stably expressing various siRNAs were retrovirally infected
with the TGL reporter gene. GFP-positive cells were enriched by fluorescence-
activated cell sorting.
Immunostaining
For immunostaining of nonmigrating cells, cells were plated onto gelatin-
coated (for MEFs) or fibronectin-coated (for MDA-MB-231 cells) glass cover-
slips at 20% confluence and allowed to grow overnight. After treatment
with or without pharmacological inhibitors (as indicated in the figures) for
2 hr, cells were fixed with 3.7% formaldehyde in PBS for 10 min at room
temperature, permeabilized with 0.1% Triton X-100 in PBS for 3 min, and
then blocked with 1% BSA in PBS for 1 hr. Cells were incubated with primary
antibody for 1 hr. After washing with PBS, cells were incubated with the appro-
priate secondary antibody for 1 hr.
Constitutively active G12V mutants of H-Ras or Rac1 were subcloned into
pBMN-IRES-GFP retroviral vector. Retroviruses encoding Ras(G12V) or
Rac1(G12V) were harvested from the growth medium of GPG29 packaging
cells transfected with the respective constructs. MEFs or MDA-MB-231 cells
were incubated with retroviruses in growth medium supplemented with
8 mg/ml polybrene at 37C for 3 hr. Cells were further cultured for 48 hr before
being used for cell migration or focal adhesion staining.
Cell Migration and Invasion Assay
Wound-healing and Boyden chamber migration assays were performed as
described previously (Guo et al., 2007; McGarrigle et al., 2006; Shan et al.,
2006; Yang and Huang, 2005). Matrigel-coated invasion inserts (BD Biosci-
ences) with 8 mm pore membranes were used for invasion assays. For Boyden
chamber assay, cells on the inside of the transwell inserts were removed
with a cotton swab, and cells on the underside of the inserts were fixed and
stained. Photographs of three random fields were taken, and the number of
cells was counted to calculate the average number of cells per field that had
transmigrated.
Cell Tracking
MDA-MB-231 cells expressing control siRNA or STIM1 and Orai1 siRNA were
cultured in a 35 mm dish overnight. The growth medium was changed to
Ringer’s solution supplemented with 5% calf serum 2 hr before recording,
and cells were maintained at 37C throughout the experiment. The random
migration of the cells was recorded with a phase contrast microscope, and
traces and migration speed of migrating cells were analyzed with MetaMorph.
Calcium Assay
Calcium assays were performed as described previously (Cvejic et al., 2004;
Yang and Huang, 2005). For measurement of store-operated Ca2+ influx,
3 mM EGTA and 2 mM thapsigargin were added to deplete internal calcium
stores. Ca2+ influx was induced by subsequent addition of 2 mM Ca2+ (free)
after store depletion.
RNA Interference
The siRNA constructs against human STIM1 and Orai1 were generated using
the pSUPER.retro vector according to the manufacturer’s instructions
(OligoEngine). The sequences used were 50-GGCTCTGGATACAGTGCTC-30
Figure 7. SKF96365 Inhibits Tumor Metastasis
(A) Inhibition of 4T1 mouse mammary tumor cell metastasis to the lungs by SKF96365 in a spontaneous metastasis model (n = 10).
(B) Inhibition of MDA-MB-231 human breast tumor cell metastasis by SKF96365 in a mouse model.
(C) Representative bioluminescent imaging of mice injected with MDA-MB-231 cells treated without SKF96365 (control, n = 7) or with SKF96365 (n = 7). The
photon flux scale is shown at the right.
Data in (A) and (B) are shown as mean ± SEM.
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Orai1 and STIM1 in Tumor Metastasisfor STIM1 and 50-CGTGCACAATCTCAACTCG-30 for Orai1. siRNA-transfected
cells were selected using puromycin and used for Ca2+ imaging, immunostain-
ing, cell migration, invasion, and metastasis assays. siRNA-resistant mutants
for STIM1 and Orai1 were obtained by site-directed mutation of the targeting
sequences without changing amino acid sequence (from GGCTCTGGATA
CAGTGCTC to GCTCTGGACACTGTGCTC for STIM1 and from CGTGCA
CAATCTCAACTCG to CGTGCATAACCTGAATTCG for Orai1). The mutants
were subcloned into pLNCX2 retroviral vector, and viruses were packaged
in GPG29 cells. Rescue experiments were conducted either by infecting siRNA
stable cell lines with rescue retrovirus or by coinfecting MDA-MB-231 cells
with siRNA retrovirus and rescue retrovirus. STIM1 siRNA results were further
confirmed with transient transfection of two pairs of siRNA oligos: 50-GGAUG
CUGUCAUUUUUUGATT-30 and 50-GGGAAGACCUCAAUUACCATT-30. Orai1
siRNA results were confirmed with stable expression of 50-TGTCCTCTAAGA
GAATAAG-30. For western blots, anti-Orai1 antibody was from NewEast
Biosciences and anti-STIM1 antibody was from Santa Cruz Biotechnology.
Live-Cell Time-Lapse Recording
MEFs transiently expressing paxillin-GFPwere plated on gelatin-coated glass-
bottomed 35 mm tissue culture dishes overnight. Cells were maintained at
37C and pH 7.4 throughout the observation period. Focal adhesion dynamics
were quantified according to Webb et al. (2004).
MDA-MB-231 Breast Tumor Metastasis in Mice
All animal work was performed in accordance with protocols approved by the
Institutional AnimalCare andUseCommitteeofWeillMedicalCollege ofCornell
University. NOD/SCID immunodeficient mice were used for experimental lung
metastasis experiments. MDA-MB-231 human breast tumor cells expressing
the TGL reporter were trypsinized and washed with PBS. This artificial TGL
reporter gene encodes a triple fusion protein with herpes simplex virus 1 thymi-
dine kinase fused to theN terminusof enhancedGFPandfirefly luciferase fused
to the C terminus of GFP (Ponomarev et al., 2004). Subsequently, 13 106 cells
in 0.2 ml PBS were injected into the lateral tail vein. Luciferase-based noninva-
sive bioluminescent imaging and analysis were performed as described previ-
ously (Minn et al., 2005a) with an IVIS Imaging System (Xenogen).
4T1 Mammary Tumor Metastasis in Mice
Female BALB/c mice (6–8 weeks old) were purchased from Charles River. 4T1
tumorcells (13106)were injectedsubcutaneously into theabdominalmammary
glandareaofmiceusing0.1mlof a single-cell suspension inPBSonday0.Start-
ing on day 7, when the tumors averaged 4–5 mm in diameter, SKF96365 or
control PBS was administered daily by intraperitoneal injection at 10 mg/kg
per mouse until day 25. On day 28, the mice were sacrificed. This dosage
regimen was well tolerated with no signs of overt toxicity. Every group included
ten mice. Numbers of metastatic 4T1 cells in lungs were determined by clono-
genic assay. In brief, lungs were removed from each mouse on day 28, finely
minced, and digested in 5 ml of enzyme cocktail containing 13 PBS and
1mg/ml collagenase type IV for 2 hr at 37C on a platform rocker. After incuba-
tion, samples were filtered through 70 mmnylon cell strainers andwashed twice
with PBS. Resulting cellswere suspended andplatedwith a series of dilutions in
10 cm tissue culture dishes in RPMI1640medium containing 60 mM thioguanine
for clonogenic growth. Since 4T1 tumor cells are resistant to 6-thioguanine,
metastasized tumorcells formed foci after 14days, atwhich time theywere fixed
with methanol and stained with 0.03%methylene blue for counting.
Histology
Ten weeks after xenografting, mice were anesthetized and subsequently
perfused with PBS and PBS-buffered 4% paraformaldehyde. Lungs were
inflated with 1% low-melting agarose, processed for paraffin-embedded
sectioning at 8 mm, and stained with H&E. For immunohistochemistry, inflated
lungs were embedded in OCT medium and cryosectioned at 10 mm. Cryosec-
tions were counterstained with Texas red-conjugated phalloidin and DAPI to
reveal actin and nuclei.
SUPPLEMENTAL DATA
The Supplemental Data include two movies and can be found with this article
online at http://www.cancercell.org/supplemental/S1535-6108(08)00438-8.
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